Johnson & Johnson (JNJ) — Stock Price, Chart & Analysis
Johnson & Johnson (JNJ) is a Healthcare stock currently trading at $259.24, up 0.88% on the day. It carries a market capitalization of $624.74B and a trailing P/E ratio of 29.87. Over the past 52 weeks, JNJ has traded between $171.81 and $274.90. Johnson & Johnson pays a dividend yielding 2.1%. View the live JNJ chart, technical opinion, analyst ratings, fundamentals and latest news below.
Johnson & Johnson (JNJ) key data
| Price | $259.24 |
| Change (today) | +0.88% |
| Previous close | $256.98 |
| Market cap | $624.74B |
| P/E ratio (TTM) | 29.87 |
| EPS (TTM) | $8.68 |
| Dividend yield | 2.1% |
| 52-week high | $274.90 |
| 52-week low | $171.81 |
| Beta | 0.23 |
| Avg. volume | 8.28M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
Frequently asked questions about Johnson & Johnson (JNJ)
How much does one share of Johnson & Johnson cost?
As of the latest update, one share of Johnson & Johnson (JNJ) trades at $259.24 (+0.88% today).
What is Johnson & Johnson's market cap?
Johnson & Johnson has a market capitalization of approximately $624.74B.
What is Johnson & Johnson's P/E ratio?
Johnson & Johnson has a trailing price-to-earnings (P/E) ratio of 29.87.
What is Johnson & Johnson's earnings per share (EPS)?
Johnson & Johnson's trailing twelve-month EPS is $8.68.
Does Johnson & Johnson pay a dividend?
Yes — Johnson & Johnson pays a dividend with a yield of 2.1% ($5.36 per share annually).
What is Johnson & Johnson's 52-week trading range?
Over the past year, JNJ has traded between $171.81 and $274.90.
What is the analyst price target for Johnson & Johnson?
The mean analyst price target for Johnson & Johnson is $272.50. This is informational only and not investment advice.
Latest Johnson & Johnson (JNJ) news
- How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62News · Aug 8, 2026
- The Portfolio Blueprint for Building $50,000 a Month in Dividend IncomeNews · Aug 8, 2026
- The 4% Rule vs. a Dividend Paycheck: Which Makes $1.25 Million Last Longer?News · Aug 7, 2026
- Johnson & Johnson (JNJ) Reaches $5.5 Billion Talc Settlement To Close Years Of LawsuitsNews · Aug 7, 2026
- The Two Divergent Paths Priced Into Eli Lilly StockNews · Aug 7, 2026
- Halozyme's Q2 Earnings Beat Estimates, 2026 Outlook Raised, Stock UpNews · Aug 7, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live JNJ dashboard…